People News

Share this article:
Seattle Genetics, a biotech focused on development and commercialization of monoclonal antibody-based therapies for cancer and autoimmune disease, announced the appointment of Bruce Seeley as EVP, commercial. The company also announced the promotion of Kirk Schumacher to VP, legal affairs and compliance, and general counsel. Seeley was most recently a senior marketing director at Genentech, for Herceptin and T-DM1. Schumacher was most recently general counsel at Seattle Genetics.

Publicis Strategic Solutions Group
named Christopher Dowd EVP, business development. In his new role, Dowd is responsible for leading business development activities, and reports to Rick Keefer, president and CEO. Dowd was most recently president of sales at Allergan.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.